Argenx is a Dutch biopharmaceutical company focused on developing antibody-based therapies for rare autoimmune diseases. The company's lead product, Vyvgart...

argenx SE American Depositary Shares (ARGX) has a valuation score of 65/100 (moderate), profitability score of 95/100 (strong), financial health score of 100/100 (strong), Piotroski F-Score of 3/9, Altman Z-Score of 31.43 (safe zone), revenue growth of +116.2% YoY.

Neutral

Analyst Consensus

Strong Buy

Wall Street consensus estimates — not a PMP forecast · Updated Aug 31, 2026

Analyst Recommendations25 analysts · 2026-08-01
8
15
2
Strong Buy 8Buy 15Hold 2Sell 0Strong Sell 0

Recent Market Moves

See all ARGX moves →
DateSessionPriceMoveZ-Score
Aug 17Pre-market$952.47+11.89%7.92
argenx SE American Depositary Shares (ARGX) Valuation & P/E History →argenx SE American Depositary Shares (ARGX) Financial Statements →
Share:

Explore More Stocks

AAPLMSFTNVDAGOOGLAMZNMETATSLAJPMWMTVView all stocks →